Relay Therapeutics Inc. (RLAY)
3.96
-0.38 (-8.86%)
At close: Jan 15, 2025, 1:44 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -3.95 | -6.59 | -5.88 | -36.14 | -2.26 | -1.79 |
| PS Ratio | 52.83 | 1.21K | 964.56 | 21.43 | n/a | n/a |
| PB Ratio | 1.79 | 1.76 | 3.25 | 2.32 | -0.83 | -0.79 |
| P/FCF Ratio | -4.43 | -7.03 | -37.52 | -16.96 | -2.02 | -1.9 |
| P/OCF Ratio | -4.49 | -7.31 | -39.27 | -17.28 | -2.27 | -1.97 |
| OCF/S Ratio | -11.76 | -166.18 | -24.56 | -1.24 | n/a | n/a |
| Debt / Equity Ratio | 0.07 | 0.06 | 0.03 | 0.03 | -0.14 | -0.00 |
| Quick Ratio | 25.44 | 15.81 | 68.20 | 73.96 | 30.08 | 61.78 |
| Current Ratio | 25.44 | 16.00 | 40.14 | 56.49 | 30.08 | 61.78 |
| Asset Turnover | 0.03 | 0.00 | 0.00 | 0.10 | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.45 | -0.27 | -0.55 | -0.06 | 0.37 | 0.44 |
| Return on Assets (ROA) | -0.41 | -0.23 | -0.49 | -0.06 | -0.17 | -0.11 |
| Return on Capital (ROIC) | -0.46 | -0.29 | -0.37 | -0.07 | -0.22 | -0.12 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 79.37% | -199.06% | -29.58% | 95.71% | n/a | n/a |
| Net Profit Margin | -1.34K% | -18.41K% | -16.40K% | -59.3% | n/a | n/a |
| Pretax Profit Margin | -1.34K% | -21.04K% | -12.01K% | -63.41% | n/a | n/a |
| Operating Profit Margin | -1.46K% | -21.67K% | -12.04K% | -67.51% | n/a | n/a |
| FCF Margin | -1.19K% | -17.27K% | -2.57K% | -126.33% | n/a | n/a |
| EBITDA Margin | -1.46K% | -22.22K% | -7.34K% | -63.21% | n/a | n/a |